Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: Results from a pilot study
Sarah Kraus, Simone Hummler, Adetunji T. Toriola, Elizabeth M. Poole, Dominique Scherer, Jana Kotzmann, Karen W. Makar, Dina Kazanov, Lior Galazan, Inna Naumov, Anna E. Coghill, David Duggan, Biljana Gigic, Nadir Arber, Cornelia M. Ulrich
Dive into the research topics of 'Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: Results from a pilot study'. Together they form a unique fingerprint.